 WILMINGTON, Del., Feb. 03, 2021 GLOBE NEWSWIRE -- Rigrodsky Law, P.A. announces that it is investigating GW Pharmaceuticals plc GW Pharmaceuticals NASDAQ GM: GWPH regarding possible breaches of fiduciary duties and other violations of law related to GW Pharmaceuticals agreement to be acquired by Jazz Pharmaceuticals plc Jazz Pharmaceuticals NASDAQ GS: JAZZ. Under the terms of the agreement, GW Pharmaceuticals shareholders will receive 20.00 worth of shares of Jazz Pharmaceuticals and 200.00 in cash per share. 